| 초록 |
Organoids, 3-dimensional mini-organs, are attracting attention as a next-generation regenerative medicine, because of excellent efficacy and safety for tissue regeneration. In this lecture, the following content will be discussed. First,, the current status and strategies of development of organoid-based regenerative medicines will be introduced. Second, we will disclose the CMC development and non-clinical results of the pipeline for bowel diseases (ATORM-S) and salivary gland diseases (ATORM-C) based on ATORM platform of the ORGANOIDSCIENCES, Ltd. Finally, we would like to discuss considerations for clinical trials and approval for organoid based regenerative medicine. |
